(A) number of incidence cases by 2035; (B) projected ASR for incidence from 2035; (C) number of prevalence cases by 2035; (D) projected ASR for prevalence by 2035; (E)number of cas... by Junjie Chen (48472)

Subjects:

Adherence to the iDSI reference case among published cost-per-DALY averted studies by Joanna Emerson (6654956)

“…Among each of 11 principles in the iDSI reference case, we translated all methodological specifications and reporting standards into a series of binary questions (satisfied or not satisfied) and awarded articles one point for each item satisfied. …”

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Sensitivity analysis for cost per disability-adjusted life-year (DALY) averted. by Maitreyi Sahu (8691129)

Subjects:

Results on the trimmed datasets with a decreasing number of papers per author available for training and testing. by Leonard Bauersfeld (16475015)

Trends in the age-standardized DALYs rates and DALYs rates due to high BMI per 100,000 population of children asthma by sex and age strata in China and the USA, 1990–2019. by Chengyue Zhang (1346655)

Proportion of PUD DALYs and deaths attributable to smoking by gender, SDI quintile, and GBD region in 1990 and 2021. by Wende Hao (10315597)

Subjects:

Global temporal trends in urolithiasis disease burden, 1990–2021. by Weitao Yao (17523658)

Subjects:

Temporal trend of migraine burden in 20-54years globally. by Weitao Yao (17523658)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Cumulative YLDs (2008–2012) per 1000 people, with 95% credible intervals, associated with nine selected chronic comorbidities, ranked from highest to lowest, by HIV status in Briti... by Ni Gusti Ayu Nanditha (6494933)

Cumulative YLLs (2008–2012) per 1000 people, with 95% credible intervals, associated with nine selected chronic comorbidities, ranked from highest to lowest, by HIV status in Briti... by Ni Gusti Ayu Nanditha (6494933)

Cumulative DALYs (2008–2012) per 1000 people, with 95% credible intervals, associated with nine selected chronic comorbidities, ranked from highest to lowest, by HIV status in Brit... by Ni Gusti Ayu Nanditha (6494933)

Existing <i>Campylobacter</i> BoD studies compiled from published literature based on year of publication. by Megan Tumulty (21161822)

Subjects:

MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Mean squared error of estimates decreases with larger datasets. by Alexander Eugene Zarebski (12078347)

Trends in the all-age numbers and age-standardized incidence, prevalence, mortality and DALYs rates of PUD by sex from 1990 to 2021. by Wende Hao (10315597)

Subjects:

S1 Fig - by Jiajia Li (184267)

DataSheet_1_The Global Burden of Type 2 Diabetes Attributable to Tobacco: A Secondary Analysis From the Global Burden of Disease Study 2019.docx by Jianjun Bai (9416141)

“…A downward trend in age-standardized mortality rate (ASMR) of T2D attributable to tobacco was observed (AAPCs= -0.24; 95% CI -0.30 to -0.18), while the ASDR increased globally since 1990 (AAPCs= 0.19; 0.11 to 0.27). …”

DataSheet_1_Global burden of type 2 diabetes in adolescents from 1990 to 2019.docx by Juan Luo (149338)

“…</p>Results<p>From 1990 to 2019, the ASIR (EAPC = 1.07) and age-standardized DALY rate (EAPC = 2.01) of T2D in adolescents showed an increasing trend. …”